Search Results

You are looking at 131 - 140 of 221 items for :

  • Refine by Access: All x
Clear All
Full access

Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study

Abi Vijenthira, Lee Mozessohn, Chenthila Nagamuthu, Ning Liu, Danielle Blunt, Shabbir Alibhai, Anca Prica, and Matthew C. Cheung

spent a significantly longer number of days in the hospital compared with nonfrail patients. During both time frames, the top 3 reasons for admission among both frail and nonfrail patients were fever/infection/neutropenia, lymphoma, and symptom

Full access

Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma

Keli Turner, Sheelu Varghese, and H. Richard Alexander

symptoms are abdominal pain and increasing abdominal girth, the latter of which may be caused by ascites. 12 , 13 Weight loss and fever are other less-common presenting symptoms. 12 , 13 In some series, a palpable abdominal mass has been described on

Full access

Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, and Michael J. Sorich

other cancer types or ICIs. Third, the data had investigator-reported AEs and there was no external validation/confirmation of AEs. Finally, the irAEs analyzed were organ-specific, and did not include constitutional symptoms such as fatigue and fever

Full access

Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer

Daniel E. Lage, Areej El-Jawahri, Charn-Xin Fuh, Richard A. Newcomb, Vicki A. Jackson, David P. Ryan, Joseph A. Greer, Jennifer S. Temel, and Ryan D. Nipp

.4% (n=72) had breast cancer; 31.5% (n=306) had another cancer type ( Table 1 ). Reasons for admission included symptom management (56.0%; n=544); fever or infections (24.6%; n=239); fatigue, weakness, or failure to thrive (13.5%; n=131); and metabolic

Full access

Metachronous Medulloblastoma in a Child With Successfully Treated Neuroblastoma: Case Report and Novel Findings of DNA Sequencing

Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky

treatment was stopped because disseminated fungal infection was suspected after the patient developed fever and neutropenia, and CT of the liver showed some nodularity but blood culture results were negative. Antifungal therapy was initiated for a total of 6

Full access

Role of Immunotherapy in the Treatment of Squamous Cell Carcinoma of the Anal Canal

Van K. Morris and Cathy Eng

disease. Most patients (56%) who received all planned doses per protocol remained alive after 12 months on study. All patients experienced treatment-related AEs, most of which were infusion-related reactions, including fevers, chills, and fatigue. Given

Full access

Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung Cancer

Jie Liu, Qingxi Yu, Xin Shelley Wang, Qiuling Shi, Jun Wang, Fan Wang, Simeng Ren, Jiayue Jin, Baojin Han, Wenzheng Zhang, Xueyao Su, Shuanghu Yuan, and Hongsheng Lin

. Radiation pneumonitis (RP), which occurs within 1 to 4 months after RT, is a clinically important toxicity in 10% to 30% of patients treated with thoracic RT, manifesting dyspnea, nonproductive cough, pleuritic chest pain, fever, and, rarely, acute

Full access

Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis

Nathan J. Moore, Megan Othus, Anna B. Halpern, Nicholas P. Howard, Linyi Tang, Kyle E. Bastys, Mary-Elizabeth M. Percival, Paul C. Hendrie, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey, and Roland B. Walter

for 1 weekly visit and when new problems arose. The physician typically saw them 1 to 2 times per cycle. All patients with neutropenic fever were admitted for intravenous antibiotics and evaluation. However, some patients were discharged to complete a

Full access

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer

Eric M. Lander, Xuanyi Li, Li-Ching Huang, Amanda S. Cass, Wade T. Iams, Emily A. Skotte, Jennifer G. Whisenant, Robert A. Ramirez, Sally J. York, Travis J. Osterman, Jennifer A. Lewis, Christine M. Lovly, Yu Shyr, and Leora Horn

Although some unplanned oncologic hospitalizations, such as for neutropenic fever due to chemotherapy, are harder for clinicians to anticipate and easier for patients to overcome, others may be the opposite: easier to predict and/or difficult to overcome

Full access

Optimizing BTK Inhibition in Waldenström Macroglobulinemia

Shayna Sarosiek and Jorge J. Castillo

sweats, flu-like symptoms, and fever. The symptoms usually resolve within 12 hours of restarting BTK inhibitor therapy. In patients who experience withdrawal symptoms, low doses of prednisone (eg, 10 mg orally twice daily or 20 mg orally once daily) can